HC Wainwright & Co. Maintains Buy on SpyGlass Pharma, Raises Price Target to $43

Benzinga · 3d ago
HC Wainwright & Co. analyst Yi Chen maintains SpyGlass Pharma (NASDAQ:SGP) with a Buy and raises the price target from $37 to $43.